Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
81 hedge funds and large institutions have $368M invested in Apollo Endosurgery, Inc. in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 11 closing their positions.
82,200% more call options, than puts
Call options by funds: $33.7M | Put options by funds: $41K
264% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 11
111% more capital invested
Capital invested by funds: $174M → $368M (+$194M)
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
53% more funds holding
Funds holding: 53 → 81 (+28)
36% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
CPMG Inc
Dallas,
Texas
|
+$16.6M |
| 2 |
JP Morgan Chase
New York
|
+$8.01M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$6.67M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.69M |
| 5 |
BSCM
Berry Street Capital Management
London,
United Kingdom
|
+$4.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.26M |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$6.26M |
| 3 |
Goldman Sachs
New York
|
-$5.57M |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$3.62M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$2.68M |
APEN Hedge Fund Activity: Q4 2022 in Review
81 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2022, worth a combined $368M — up 111% from $174M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new APEN positions and 11 closed out — a net gain of 29 holders — while 19 added to existing stakes and 14 trimmed.
The largest buyer was CPMG Inc, adding an estimated $16.6M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $6.26M sold.
- 81 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2022, up from 53 in Q3 2022.
- Funds reported $368M of Apollo Endosurgery, Inc. stock for Q4 2022, up 111% quarter-over-quarter.
- 40 funds opened new Apollo Endosurgery, Inc. positions in Q4 2022 and 11 closed out, a net change of +29 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q4 2022 was CPMG Inc, an estimated $16.6M added.
- The largest Apollo Endosurgery, Inc. seller in Q4 2022 was Soleus Capital Management, an estimated $6.26M sold.
Based on aggregated 13F filings for Q4 2022.